Literature DB >> 18512633

Implementation and effects of a medication pass nutritional supplement program in a long-term care facility: a pilot study.

Michelle Doll-Shankaruk1, Walter N C Yau, Carol Oelke.   

Abstract

The purpose of this 6-month study was to determine the most effective method for implementing an interdisciplinary medication pass nutritional supplement program in Extendicare's long-term care facilities in western Canada by piloting the program in one facility. The program's effects on residents' body weight, skin integrity, and laboratory values related to nutritional status were evaluated. Resident adherence and staff perception were also assessed. Findings indicated that most residents experienced weight gain and improved visceral protein status. Resident adherence to the program was 96%, and staff feedback was positive. The promising results of this pilot study suggest that a medication pass nutritional supplement program could help improve the nutritional status of long-term care residents, thereby resulting in improved quality of life.

Entities:  

Mesh:

Year:  2008        PMID: 18512633     DOI: 10.3928/00989134-20080501-02

Source DB:  PubMed          Journal:  J Gerontol Nurs        ISSN: 0098-9134            Impact factor:   1.254


  2 in total

1.  Energy and protein intake in medical and geriatric inpatients with MEDPass versus conventional administration of oral nutritional supplements: study protocol for the randomized controlled MEDPass Trial.

Authors:  Silvia Kurmann; Emilie Reber; Maria F Vasiloglou; Philipp Schuetz; Andreas W Schoenenberger; Katja Uhlmann; Anna-Barbara Sterchi; Zeno Stanga
Journal:  Trials       Date:  2021-03-16       Impact factor: 2.279

2.  Study of the Inhibitory Effects of Enteral Nutrition Formula on Indomethacin-Induced Gastric Lesions in Mice.

Authors:  Takeshi Yoshimi; Yoshiaki Yamagishi; Issei Kanegawa; Megumi Suda; Rei Saiki; Ken-Ichiro Tanaka; Hitomi Goda; Toshiyuki Kudo; Kiyomi Ito
Journal:  Nutrients       Date:  2019-12-14       Impact factor: 5.717

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.